Categories: GlobalHealthLatest

EU Regulator Prepares To Issue Advice on Use of J&J Vaccine

Experts at the European Medicines Agency are preparing to present the conclusions of their investigation into possible links between the Johnson & Johnson coronavirus vaccine and very rare cases of unusual clotting disorders detected in the US.

Last week, J&J halted its European rollout of its one-dose vaccine after the U.S. Food and Drug Administration recommended officials pause its use while the rare blood clot cases are examined. Officials identified six cases of the highly unusual blood clots among nearly 7 million people who were immunized with the shot in the US.

Johnson & Johnson advised European governments to store their doses until the EU drug regulator issued guidance on their use; widespread use of the shot in Europe has not yet started.

The delay was a further blow to vaccination efforts in the European Union, which have been plagued by supply shortages, logistical problems and concerns over unusual blood clots also in a small number of people who received the AstraZeneca COVID-19 vaccine. Experts worry the temporary halt on J&J’s shot could further shake vaccine confidence and complicate worldwide COVID-19 immunization efforts.

Last week, South Africa suspended its use of the vaccine in the wake of the U.S. pause, and countries including Italy, Romania, the Netherlands, Denmark and Croatia put their J&J doses into storage.

The blood clots linked to the J&J vaccine are occurring in unusual parts of the body, such as veins that drain blood from the brain. Those patients also have abnormally low levels of blood platelets, a condition normally linked to bleeding, not clotting.

With the AstraZeneca vaccine, scientists in Norway and Germany have suggested that some people are experiencing an abnormal immune system response, forming antibodies that attack their own platelets.

On Monday, World Health Organization Director-General Tedros Adhanom Ghebreyesus said more than 5 million new cororavirus cases were confirmed worldwide last week, the highest-ever number in a single week. He noted that cases and hospitalizations among younger people were “increasing at an alarming rate.”

The European Medicines Agency, which regulates drugs used in European Union member nations, said last month there was a “possible link” between the AstraZeneca vaccine and rare blood clots but said the benefits of vaccination far outweighed the risks of COVID-19. It noted the risk is less than the blood clot risk that healthy women face from birth control pills.

The European Union ordered 200 million doses of the Johnson & Johnson for 2021 and EU officials had hoped the one-shot vaccine could be used both to boost the continent’s lagging vaccination rates and to protect hard-to-reach populations, like migrant workers and the homeless.

Follow us on:

AriseNews

Recent Posts

Trump Nominates Billion Dollar Buyer Host Tilman Fertitta as US Ambassador to Italy

Donald Trump has selected businessman Tilman Fertitta, owner of the Houston Rockets, to serve as…

45 minutes ago

Ten Family Members Die in Private Plane Crash in Brazil

A plane crash in Gramado, Brazil, killed ten family members, including businessman Luiz Claudio Galeazzi,…

56 minutes ago

Man Arrested in New York for Setting Woman on Fire in Brooklyn Subway

A suspect has been apprehended in Brooklyn subway after woman was set ablaze and died…

59 minutes ago

Bridge Collapse In Brazil Kills One, Spills Sulfuric Acid Into River

A Brazilian bridge collapse has killed one person and spilled sulfuric acid into the Tocantins…

1 hour ago

Anambra Police Confirm 22 dead in Stampede as Governor Soludo Mandates Safety Protocols for Future Palliative Distributions

Governor Soludo has expressed grief over Okija stampede, urges safety-first approach for future food distribution…

1 hour ago

Slovak PM Robert Fico Surprises Putin in Moscow, Discusses Gas Supplies and Ukraine Conflict

Slovak PM Robert Fico made a surprise visit to Moscow for gas talks with Putin,…

1 hour ago